Kintara Therapeutics Inc (NASDAQ:KTRA)

0.5778
Delayed Data
As of Dec 03
 -0.0566 / -8.98%
Today’s Change
0.56
Today|||52-Week Range
3.35
-54.86%
Year-to-Date
SECTOR
Distribution Services
INDUSTRY
Wholesale Distributors
MARKET CAP
$30.2M

Company Description

Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. It focuses on VAL-083 and REM-001 pipelines. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.

Contact Information

Kintara Therapeutics, Inc.
12707 High Bluff Drive
San Diego California 92130
P:(858) 350-4364
Investor Relations:

Employees

Shareholders

Other institutional8.41%
Mutual fund holders3.93%
Individual stakeholders1.06%

Top Executives

Robert E. HoffmanChairman, President & Chief Executive Officer
Greg A. JohnsonOperations Head
Scott PraillChief Financial Officer & Secretary
Dennis M. BrownChief Scientific Officer
Steven RychnovskyVice President-Research & Development